BioCentury
ARTICLE | Company News

Rigel Inc., Novartis Pharma AG deal

November 1, 1999 8:00 AM UTC

Rigel will use its functional genomics technology over five years to identify and validate small molecule, orally active drug targets that mediate functions of B cells involved in autoimmune diseases....